John Lunger, Chief Patient Supply Officer at Adaptimmune Therapeutics PLC (ADAP), sold 22,795 shares at $0.67 ($16K) on 2024-01-17, disclosed to the SEC on 2024-01-17.
Seasonal sale ($16k) by Chief Patient Supply Officer — this insider has traded ADAP in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.79 | 4,681 | $4K | 23.4% |
| 2 | $0.67 | 5,309 | $4K | 22.5% |
| 3 | $0.67 | 12,805 | $9K | 54.2% |
| Total | $0.69 avg | 22,795 | $16K | 100% |
| Filing → |
| ADAP | SELL | 2024-01-12 | $8K | — | Filing → |
| ADAP | SELL | 2023-08-01 | $3K | — | Filing → |
| ADAP | SELL | 2023-01-17 | $8K | — | Filing → |